This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://linked.opendata.cz/resource/drugbank/drug/DB08435/identifier/pdb/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08435/identifier/pubchem-compound/
n11http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB08435/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08435/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08435
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB08435 n12:DB08435
dcterms:title
(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid
adms:identifier
n6:DB08435 n7:99444906 n8:PTG n9:23654841
n3:IUPAC-Name
n4:271B57D4-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B57DA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B57D9-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B57D6-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B57D7-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B57D8-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B57D2-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B57D0-363D-11E5-9242-09173F13E4C5 n4:271B57D3-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B57D1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B57E0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B57E1-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B57DB-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B57DC-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B57DE-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B57DD-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B57DF-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B57E6-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B57E8-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B57E9-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B57E5-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B57E4-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B57E7-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B57D5-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B57E2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B57E3-363D-11E5-9242-09173F13E4C5